Previous research showed that localized treatment of LV injuries with αCT1 resulted in a decreased propensity to develop arrhythmia in response to programmed stimulation and ischaemic injury, which was attributed to αCT1 inducing an increase in PKC-mediated Cx43-pS368 levels [36]. This evidence concerns the gene GJA1 and cardiac arrhythmia.